top of page

Our team is composed of expert scientists in drug development, neurosciences, immunology, mental health and clinical sciences. This is synergizedby business development, regulatory sciences and market access strategies.


Lucid Psycheceuticals was founded in 2020 and built its pipeline very quickly by in-house and licensing activity. We were very fortunate to have a strong team of investors supporting the company in early days.  In 2021, Lucid was acquired by FSD Pharma, a synergistic boost to Lucid activities.

Lucid team has significantly increased since acquisition by FSD Pharma, synergizing FSD Pharma activities significantly.  For an upto date information on our complete team and corporate structure, please visit this link.

bottom of page